Form 8-K - Current report:
SEC Accession No. 0001479681-25-000008
Filing Date
2025-03-31
Accepted
2025-03-31 16:12:15
Documents
16
Period of Report
2025-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nutx-20250331x8k.htm   iXBRL 8-K 29808
2 EX-99 nutx-20250331xex99.htm EX-99 506999
3 GRAPHIC nutx-20250331xex99001.jpg GRAPHIC 4252
  Complete submission text file 0001479681-25-000008.txt   698413

Data Files

Seq Description Document Type Size
4 EX-101.SCH nutx-20250331.xsd EX-101.SCH 4127
5 EX-101.DEF nutx-20250331_def.xml EX-101.DEF 2856
6 EX-101.LAB nutx-20250331_lab.xml EX-101.LAB 17254
7 EX-101.PRE nutx-20250331_pre.xml EX-101.PRE 11370
18 EXTRACTED XBRL INSTANCE DOCUMENT nutx-20250331x8k_htm.xml XML 4831
Mailing Address 6030 S. RICE AVE. SUITE C HOUSTON TX 77081
Business Address 6030 S. RICE AVE. SUITE C HOUSTON TX 77081 (713) 660-0557
Nutex Health, Inc. (Filer) CIK: 0001479681 (see all company filings)

EIN.: 113363609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41346 | Film No.: 25793359
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)